Catalyst Wire Dossier Catalyst Wire Dossier

YUSIMRY

ADALIMUMAB-AQVH · Coherus BioSciences Inc
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for YUSIMRY, covering 2021-12-17 to 2025-11-10. Get the full timeline:

Most recent: FDA Approved: YUSIMRY — Supplemental Application (Coherus BioSciences Inc)

See pricing